I-Respond Evaluation of Irbesartan (with Or Without HCTZ) In Improving Insulin Sensitivity In Hypertensive Patients with Metabolic Syndrome Trademark Details

I-Respond Evaluation of Irbesartan (with or Without Hctz) in Improving Insulin Sensitivity in Hypertensive Patients with Metabolic Syndrome was registered on Tuesday, April 22, 2008 and is currently owned by Sanofi under the registration number 3414636 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 9 years ago on Friday, November 28, 2014, according to the United State Patent & Trademark Office
Word Mark I-Respond Evaluation of Irbesartan (with or Without Hctz) in Improving Insulin Sensitivity in Hypertensive Patients with Metabolic Syndrome
Status Dead Registered 710 — Cancelled - Section 8

Current Owner

Sanofi of Paris, TX

View all trademarks for Sanofi
Other Trademarks for Sanofi

Previous Owners

Sanofi-Aventis of Paris, TX

View all trademarks for Sanofi-Aventis
Other Trademarks for Sanofi-Aventis
Serial Number 78902550
Registration Number 3414636
Status Date Friday, November 28, 2014
Filing Date Friday, November 28, 2014
Registration Date Tuesday, April 22, 2008
Attorney G. Mathew Lombard
Domestic Representative G. Mathew Lombard

Correspondent

G. Mathew Lombard
Lombard & Geliebter LLP
1115 Broadway, 12th Floor
New York NY 10010

Case File Statements

Indication of Colors The color(s) blue and pink is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text "Evaluation of Irbesartan (with or Without Hctz) in Improving Insulin Sensitivity in Hypertensive Patients with Metabolic Syndrome"
Description of Mark The mark consists of the word i-RESPOND in blue over which there is a curved bar or line in pink. The hyphen of "i-RESPOND" is pink. The remaining element(s) of the mark appear under the i-RESPOND element in significantly smaller size in blue
Goods & Services Clinical research in the field of hypertension and anti-hypertensive pharmaceuticals; medical and scientific research, namely, conducting clinical trials for anti-hypertensive pharmaceuticals

Classifications

International Class Codes
042 — Class 42 includes mainly services provided by persons, individually or collectively, in relation to the theoretical and practical aspects of complex fields of activities; such services are provided by members of professions such as chemists, physicists, engineers, computer programmers, etc.
U.S. Class Codes 100, 101
Status 2 — Sec. 8 – Entire Registration
Status Date Friday, November 28, 2014
Primary Code 042

You must be signed in to print.

Once signed in, look for the PDF button.